Glenmark Pharmaceuticals consolidated net profit rises 930.34% in the June 2026 quarter

Sales rise 28.52% to Rs 3931.73 crore

Net profit of Glenmark Pharmaceuticals rose 930.34% to Rs 482.92 crore in the quarter ended June 2026 as against Rs 46.87 crore during the previous quarter ended June 2025. Sales rose 28.52% to Rs 3931.73 crore in the quarter ended June 2026 as against Rs 3059.33 crore during the previous quarter ended June 2025.

Particulars	Quarter Ended
	Jun. 2026	Jun. 2025	% Var.
Sales	3931.73	3059.33	29
OPM %	20.47	18.98	-
PBDT	816.56	548.73	49
PBT	643.39	418.81	54
NP	482.92	46.87	930

Powered by Capital Market - Live News